查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1670264

2025 年全球左心室辅助装置市场报告

Left Ventricular Assist Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年左心室辅助装置市场规模将强劲成长。到 2029 年，这一数字将成长至 25.2 亿美元，复合年增长率为 9.6%。预测期内的成长将归因于适应症的扩大、心臟衰竭病例数量的增加、患者预后的改善、市场核准和法规的变化以及对目的治疗的关注。预测期内的主要趋势包括植入技术的进步、双泵系统的发展、作为目的治疗的日益广泛使用、注重降低感染风险、与心臟衰竭管理计划的结合以及抗凝血管理的改善。

心血管疾病发生率的不断上升预计将在未来几年推动左心室辅助装置市场的成长。心血管疾病包括多种影响心臟和血管的疾病，例如心臟疾病和先天性心臟疾病。当心臟衰竭进展时，左心室辅助装置支撑心臟的左心室，负责将血液泵送到身体组织。例如，根据英国政府机构健康改善与差异办公室 2024 年 3 月发布的资料，2023 年英格兰有超过 1,862,500 人（3%）被诊断出患有心臟疾病(CHD)。此外，2022 年 12 月，纽约州政府的资料显示，心臟病每年在美国导致约 697,000 人死亡，相当于每五人中就有一人死于心臟病。每年，大约有 805,000 名美国人会经历心臟病发作：其中 605,000 人是首次心臟病发作，而 20 万人是先前心臟病发作的结果。因此，心血管疾病盛行率的上升正在推动左心室辅助装置市场的成长。

预计未来几年医疗保健支出的增加将推动左心室辅助装置市场的成长。医疗保健支出包括与提供基于健康的卫生服务、计划生育活动、营养计划、紧急援助等相关的所有费用。医疗保健支出的增加正在推动各种健康相关产品的进步和发展，包括左心室辅助装置。增加医疗保健支出可能会对左心室辅助装置市场的成长产生正面影响。例如，英国国家统计机构国家统计局报告称，2022年英国医疗保健支出达到约3,548.8亿美元（2,830亿英镑），与2021年支出相比名义成长0.7%。因此，医疗保健支出的增加正在推动左心室辅助装置市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 世界左心室辅助循环装置PESTEL分析（政治、社会、科技、环境、法律因素、促进因素、抑制因素）
  • 最终用途产业分析
  • 全球左心室辅助装置市场：成长率分析
  • 全球左心室辅助装置市场表现：规模与成长，2019 年至 2024 年
  • 全球左心室辅助装置市场预测：2024-2029 年及 2034 年规模与成长
  • 全球左心室辅助装置总目标市场 (TAM)

第六章 市场细分

  • 全球左心室辅助装置市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 经皮左心室辅助循环装置
  • 植入式左心室辅助装置
  • 全球左心室辅助装置市场流量（按类型、实际和预测），2019-2024 年、2024-2029 年、2034 年
  • 脉动
  • 非脉动
  • 全球左心室辅助装置市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 復健桥樑 (BTR) 治疗
  • 移植前桥接 (BTT) 治疗
  • 目的地治疗
  • 候选人资格桥樑 (BTC) 治疗
  • 全球左心室辅助装置市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
  • 心臟中心
  • 医院
  • 全球左心室辅助装置市场经皮左心室辅助装置细分市场按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 临时经皮装置
  • 永久性经皮装置
  • 全球左心室辅助装置市场，按植入式左心室辅助装置类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 连续流装置
  • 脉动流装置

第七章 区域和国家分析

  • 全球左心室辅助装置市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球左心室辅助装置市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 左心室辅助装置市场：竞争格局
  • 左心室辅助装置市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
    • MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • LivaNova Plc
  • Thoratec Corporation
  • Abiomed Inc
  • Transonic Systems
  • Berlin Heart GmbH
  • BioVentrix
  • Cleveland Heart Inc.
  • Jarvik Heart Inc.
  • CorWave SA
  • SynCardia Systems LLC
  • NuPulseCV Inc.
  • Fineheart
  • Procyrion Inc
  • Carmat SA
  • BiVACOR Inc

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年左心室辅助装置市场：提供新机会的国家
  • 2029 年左心室辅助装置市场：提供新机会的细分市场
  • 2029 年左心室辅助装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r25064

A left ventricular assist device (LVAD) serves as a mechanical pump implanted in heart failure patients, assisting the heart's lower left chamber (left ventricle) in pumping blood to the aorta and throughout the body.

The primary types of left ventricular assist devices include transcutaneous left ventricular assist devices and implantable left ventricular assist devices. A transcutaneous left ventricular assist device is characterized by having both an external power supply and an internal pump located inside the body. Tubes connect the pump to the heart through small openings in the abdomen. This type of LVAD is often employed for short-term support during or following surgery. Left ventricular assist devices can have either pulsatile or non-pulsatile flows, and they are used in various therapeutic approaches such as bridge-to-recovery (BTR) therapy, bridge-to-transplant (BTT) therapy, destination therapy, and bridge-to-candidacy (BTC) therapy. Cardiology centers and hospitals typically utilize these devices for patient care.

The left ventricular assist devices market research report is one of a series of new reports from The Business Research Company that provides left ventricular assist devices market statistics, including the left ventricular assist devices industry's global market size, regional shares, competitors with a left ventricular assist devices market share, detailed left ventricular assist devices market segments, market trends, and opportunities, and any further data you may need to thrive in the left ventricular assist devices industry. This left ventricular assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.6 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to post-market surveillance and data, reduction in device size and noise, awareness and education programs, increased physician experience, and adoption in bridge therapy

The left ventricular assist devices market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanded indications, a rise in heart failure cases, enhanced patient outcomes, market approval and regulatory changes, focus on destination therapy. Major trends in the forecast period include advancements in implantation techniques, development of dual-pump systems, growing use as a destination therapy, focus on minimizing infection risks, integration with heart failure management programs, and improved anticoagulation management.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the left ventricular assist device market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease and congenital heart disease, among others. In cases of advanced heart failure, a left ventricular assist device supports the heart's left ventricle, which is responsible for pumping blood to the body's tissues. For example, in March 2024, data released by the Office for Health Improvement and Disparities, a UK government agency, indicated that there were over 1,862,500 individuals (3%) diagnosed with coronary heart disease (CHD) in England in 2023. Additionally, in December 2022, data from the New York government revealed that heart disease is responsible for approximately 697,000 deaths annually in the United States, equating to 1 in every 5 fatalities. Each year, around 805,000 Americans experience a heart attack, with 605,000 being their first and 200,000 resulting from previous heart attacks. Therefore, the rising prevalence of cardiovascular diseases is fueling the growth of the left ventricular assist device market.

The increase in healthcare expenditures is expected to drive the growth of the left ventricular assist device market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. Higher healthcare spending can facilitate the advancement and development of various health-related products, including left ventricular assist devices. As healthcare expenditures rise, they will positively impact the growth of the left ventricular assist device market. For example, in 2022, the Office for National Statistics, a UK national statistics organization, reported that healthcare expenditure in the UK reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to spending in 2021. Thus, the rise in healthcare expenditures is propelling the growth of the left ventricular assist device market.

Leading companies in the left ventricular assist devices market are focusing on developing technologies like power management units (PMUs) to improve the efficiency, reliability, and longevity of these devices. A power management unit (PMU) is an integrated circuit responsible for regulating and managing the power supply and distribution to various components within electronic devices. For example, in June 2022, Renesas Electronics, a semiconductor manufacturer based in Japan, introduced the SmartBond DA1470x. This family of products marks a significant advancement in Bluetooth Low Energy (BLE) technology, offering developers a versatile platform for creating innovative IoT products while optimizing costs and enhancing performance. The high level of integration in the SmartBond DA1470x simplifies design, boosts reliability, and shortens time-to-market across various applications.

Major companies in the left ventricular assist device industry are significantly investing in research, development, and early feasibility trials for their Total Artificial Heart (TAH). This substantial investment aligns with long-term goals, as demonstrated by BiVACOR, a US-based medical technology company that secured $18 million in funding for TAH development in March 2023. Led by Cormorant Asset Management and OneVentures, these funds will support research, early feasibility trials, and key executive hires. The BiVACOR TAH, designed for severe biventricular heart failure, incorporates advancements from Left Ventricular Assist Device (LVAD) technology, signaling a shift toward durable rotary blood pumps.

In December 2022, Johnson & Johnson, a prominent US-based pharmaceutical and medical technology company, completed the acquisition of Abiomed Inc for $16.6 billion. This strategic acquisition aimed to expand Johnson & Johnson's presence in the high-growth cardiovascular markets. Abiomed Inc., a US-based medical device technology company, specializes in providing circulatory and oxygenation support devices, including ventricular assist technology that pumps blood from the left ventricle (LV).

Major companies operating in the left ventricular assist devices market include Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp

North America was the largest region in the left ventricular assist devices market in 2024. The regions covered in the left ventricular assist devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the left ventricular assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The left ventricular assist devices market consists of sales of rechargeable left ventricular assist devices, non-rechargeable left ventricular assist devices, heart pumps, and controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Left Ventricular Assist Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on left ventricular assist devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for left ventricular assist devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The left ventricular assist devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Transcutaneous Left Ventricular Assist Devices; Implantable Left Ventricular Assist Devices
  • 2) By Type Of Flow: Pulsatile; Non-Pulsatile
  • 3) By Application: Bridge-To-Recovery (BTR) Therapy; Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Candidacy (BTC) Therapy
  • 4) By End-User: Cardiology Centers; Hospitals
  • Subsegments:
  • 1) By Transcutaneous Left Ventricular Assist Devices: Temporary Transcutaneous Devices; Permanent Transcutaneous Devices
  • 2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices; Pulsatile Flow Devices
  • Companies Mentioned: Abbott Laboratories; Medtronic plc.; Terumo Corporation; St. Jude Medical; MAQUET GmbH & Co.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Left Ventricular Assist Devices Market Characteristics

3. Left Ventricular Assist Devices Market Trends And Strategies

4. Left Ventricular Assist Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Left Ventricular Assist Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Left Ventricular Assist Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Left Ventricular Assist Devices Market Growth Rate Analysis
  • 5.4. Global Left Ventricular Assist Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Left Ventricular Assist Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Left Ventricular Assist Devices Total Addressable Market (TAM)

6. Left Ventricular Assist Devices Market Segmentation

  • 6.1. Global Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Left Ventricular Assist Devices
  • Implantable Left Ventricular Assist Devices
  • 6.2. Global Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulsatile
  • Non-Pulsatile
  • 6.3. Global Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bridge-To-Recovery (BTR) Therapy
  • Bridge-To-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-To-Candidacy (BTC) Therapy
  • 6.4. Global Left Ventricular Assist Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiology Centers
  • Hospitals
  • 6.5. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Transcutaneous Left Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Temporary Transcutaneous Devices
  • Permanent Transcutaneous Devices
  • 6.6. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Implantable Left Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Flow Devices
  • Pulsatile Flow Devices

7. Left Ventricular Assist Devices Market Regional And Country Analysis

  • 7.1. Global Left Ventricular Assist Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Left Ventricular Assist Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Left Ventricular Assist Devices Market

  • 8.1. Asia-Pacific Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Left Ventricular Assist Devices Market

  • 9.1. China Left Ventricular Assist Devices Market Overview
  • 9.2. China Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Left Ventricular Assist Devices Market

  • 10.1. India Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Left Ventricular Assist Devices Market

  • 11.1. Japan Left Ventricular Assist Devices Market Overview
  • 11.2. Japan Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Left Ventricular Assist Devices Market

  • 12.1. Australia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Left Ventricular Assist Devices Market

  • 13.1. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Left Ventricular Assist Devices Market

  • 14.1. South Korea Left Ventricular Assist Devices Market Overview
  • 14.2. South Korea Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Left Ventricular Assist Devices Market

  • 15.1. Western Europe Left Ventricular Assist Devices Market Overview
  • 15.2. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Left Ventricular Assist Devices Market

  • 16.1. UK Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Left Ventricular Assist Devices Market

  • 17.1. Germany Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Left Ventricular Assist Devices Market

  • 18.1. France Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Left Ventricular Assist Devices Market

  • 19.1. Italy Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Left Ventricular Assist Devices Market

  • 20.1. Spain Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Left Ventricular Assist Devices Market

  • 21.1. Eastern Europe Left Ventricular Assist Devices Market Overview
  • 21.2. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Left Ventricular Assist Devices Market

  • 22.1. Russia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Left Ventricular Assist Devices Market

  • 23.1. North America Left Ventricular Assist Devices Market Overview
  • 23.2. North America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Left Ventricular Assist Devices Market

  • 24.1. USA Left Ventricular Assist Devices Market Overview
  • 24.2. USA Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Left Ventricular Assist Devices Market

  • 25.1. Canada Left Ventricular Assist Devices Market Overview
  • 25.2. Canada Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Left Ventricular Assist Devices Market

  • 26.1. South America Left Ventricular Assist Devices Market Overview
  • 26.2. South America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Left Ventricular Assist Devices Market

  • 27.1. Brazil Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Left Ventricular Assist Devices Market

  • 28.1. Middle East Left Ventricular Assist Devices Market Overview
  • 28.2. Middle East Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Left Ventricular Assist Devices Market

  • 29.1. Africa Left Ventricular Assist Devices Market Overview
  • 29.2. Africa Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Left Ventricular Assist Devices Market Competitive Landscape And Company Profiles

  • 30.1. Left Ventricular Assist Devices Market Competitive Landscape
  • 30.2. Left Ventricular Assist Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

31. Left Ventricular Assist Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova Plc
  • 31.2. Thoratec Corporation
  • 31.3. Abiomed Inc
  • 31.4. Transonic Systems
  • 31.5. Berlin Heart GmbH
  • 31.6. BioVentrix
  • 31.7. Cleveland Heart Inc.
  • 31.8. Jarvik Heart Inc.
  • 31.9. CorWave SA
  • 31.10. SynCardia Systems LLC
  • 31.11. NuPulseCV Inc.
  • 31.12. Fineheart
  • 31.13. Procyrion Inc
  • 31.14. Carmat SA
  • 31.15. BiVACOR Inc

32. Global Left Ventricular Assist Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Left Ventricular Assist Devices Market

34. Recent Developments In The Left Ventricular Assist Devices Market

35. Left Ventricular Assist Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Left Ventricular Assist Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Left Ventricular Assist Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Left Ventricular Assist Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer